Stock Market Reviews

Read and share opinions on TNDM (Tandem Diabetes Care, Inc.) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the stock mark

Latest News

• Is Tandem Diabetes Care (TNDM) Still Undervalued After Its Recent Share Price Rebound?
  Dec 26, 2025
• Unpacking Q3 Earnings: Tandem Diabetes (NASDAQ:TNDM) In The Context Of Other Healthcare Technology Stocks
  Dec 19, 2025
• Reasons to Hold Tandem Diabetes Stock in Your Portfolio for Now
  Dec 9, 2025
• Tandem Diabetes (TNDM) Stock Is Up, What You Need To Know
  Dec 3, 2025
• Assessing Tandem Diabetes Care’s (TNDM) Valuation After Legal Probe and t:slim X2 Pump Correction Announcement
  Dec 3, 2025
• Tandem Diabetes Care Announces Appointment of Sandra Beaver to Board of Directors
  Nov 12, 2025
• Tandem Mobi Receives FDA Clearance for Use with Android Smartphones
  Nov 10, 2025

TNDM News

• Is Tandem Diabetes Care (TNDM) Still Undervalued After Its Recent Share Price Rebound?
  Tandem Diabetes Care (TNDM) has quietly staged a sharp rebound, with shares climbing roughly 9% over the past month and nearly doubling in the past 3 months, despite still sitting well below year-ago levels. See our latest analysis for Tandem Diabetes Care. That rebound reflects a shift in sentiment, with the strong 90 day share price return of 87.33% coming after a rough stretch that left the year to date share price return at negative 37.28% and the 1 year total shareholder return at...
  Dec 26, 2025
• What Tandem Diabetes Care (TNDM)'s Canadian Smartphone Bolus Launch Means For Shareholders
  In December 2025, Tandem Diabetes Care announced that its Tandem t:slim mobile app became available in Canada for Android and iOS users, enabling smartphone-based bolus delivery, pump data viewing, and wireless uploads to the Tandem Source cloud platform for t:slim X2 pumps running version 7.8.1 or higher. This rollout meaningfully deepens Tandem’s connected-care ecosystem, potentially increasing user engagement and data utilization by allowing pump control and therapy insights directly from...
  Dec 25, 2025
• Medtronic’s diabetes spinoff MiniMed files for IPO
  MiniMed is pitching the breadth of its portfolio as an advantage over more focused rivals such as Dexcom and Insulet.
  Dec 22, 2025
• Unpacking Q3 Earnings: Tandem Diabetes (NASDAQ:TNDM) In The Context Of Other Healthcare Technology Stocks
  The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how healthcare technology stocks fared in Q3, starting with Tandem Diabetes (NASDAQ:TNDM).
  Dec 19, 2025
• Tandem t:slim Mobile App Now Available in Canada
  SAN DIEGO, December 18, 2025--Tandem t:slim mobile application is now available for Android and iOS users in Canada.
  Dec 18, 2025
• Here Are Tuesday’s Top Wall Street Analyst Research Calls: Allstate, Chubb Ltd., Eli Lilly, KLA Corp., Lockheed Martin, MongoDB, Roku, and More
  Pre-Market Stock Futures: The futures are trading lower after what started as a bounce-back Monday turned into a reversal Monday, as the AI/Datacenter rotation trade continues to gather steam during the last whole trading week of 2025. Stocks rallied Monday on the open as traders tried to inject some holiday spirit, but by 12 noon ... Here Are Tuesday’s Top Wall Street Analyst Research Calls: Allstate, Chubb Ltd., Eli Lilly, KLA Corp., Lockheed Martin, MongoDB, Roku, and More
  Dec 16, 2025
• Does Tandem Diabetes Care’s Slumping Share Price Signal a New Opportunity in 2025?
  Wondering if Tandem Diabetes Care at around $21 a share is a hidden bargain or a value trap? You are not alone, and that is exactly what we are going to unpack here. The stock has bounced 2.2% over the last week and 14.9% over the past month, but that is coming off a tough backdrop, with the share price still down 40.3% year to date and 34.5% over the last year. Recently, investors have been refocusing on Tandem's position in the insulin pump market and how its technology stacks up against...
  Dec 14, 2025
• Don't Buy Tandem Diabetes Care Until This Big Thing Happens
  The company's challenges might not be insurmountable, but they are serious enough to warrant a healthy dose of skepticism.
  Dec 12, 2025
• Reasons to Hold Tandem Diabetes Stock in Your Portfolio for Now
  TNDM's global expansion and strategic integrations fuel growth potential, even as pump reliance and macro pressures weigh on performance.
  Dec 9, 2025
• 1 Small-Cap Stock to Consider Right Now and 2 We Brush Off
  Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and their stock prices) often stay small because their subscale operations make it harder to expand their competitive moats.
  Dec 8, 2025
• Tandem Diabetes (TNDM) Stock Is Up, What You Need To Know
  Shares of diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) jumped 4.5% in the afternoon session after an analyst at Morgan Stanley raised the firm's price target for the stock. The firm's analyst, Patrick Wood, kept an 'Equal-Weight' rating on Tandem Diabetes Care but increased the price target by over 35%, moving it from $17.00 to $23.00. This adjustment suggested a more positive outlook on the stock's value, even while the overall rating remained neutral. The action indicated tha
  Dec 3, 2025
• Assessing Tandem Diabetes Care’s (TNDM) Valuation After Legal Probe and t:slim X2 Pump Correction Announcement
  Rosen Law Firm’s probe into Tandem Diabetes Care (TNDM) after a voluntary correction of certain t:slim X2 insulin pumps, and the roughly 20% share drop that followed, has investors reassessing risk and opportunity. See our latest analysis for Tandem Diabetes Care. That legal overhang is landing on a stock that has been extremely volatile, with a 30 day share price return of 36.63% and a 90 day gain of 58.35% contrasting sharply with a 1 year total shareholder return of negative 39.22%. This...
  Dec 3, 2025
• 2 Momentum Stocks with Solid Fundamentals and 1 We Turn Down
  Exciting developments are taking place for the stocks in this article. They’ve all surged ahead of the broader market over the last month as catalysts such as new products and positive media coverage have propelled their returns.
  Nov 21, 2025
• Align Technology, Tandem Diabetes, Integra LifeSciences, Lantheus, and Inspire Medical Systems Shares Skyrocket, What You Need To Know
  A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an interest rate cut. New York Federal Reserve President John Williams stated he sees “room for a further adjustment” in the near term, sparking a significant market rally. Following his remarks, the probability of the central bank cutting rates at its December meeting jumped from 39% to over 73%, according to the CME FedWatch tool. This positive sentiment provided relief to
  Nov 21, 2025
• Tandem Diabetes Care (TNDM) Is Up 23.1% After FDA Clears Android App for Mobi System – Has the Bull Case Changed?
  In November 2025, Tandem Diabetes Care announced FDA clearance for the Android version of its Tandem Mobi mobile app, enabling broader access to its automated insulin delivery system for Android smartphone users in the United States. This expansion to Android devices marks a significant product milestone that could support improved engagement between patients and healthcare providers and facilitate increased adoption among a wider user base. We'll explore how expanding availability of the...
  Nov 13, 2025
• 5 Insightful Analyst Questions From Tandem Diabetes’s Q3 Earnings Call
  Tandem Diabetes’ third quarter was marked by improved operational efficiency and commercial execution, resulting in a positive market reaction. Management credited the quarter’s performance to the ongoing modernization of U.S. commercial operations, increased pricing contributions from both traditional and pharmacy channels, and early traction from new product offerings. CEO John Sheridan highlighted that changes in sales processes and organizational restructuring began to yield tangible results
  Nov 13, 2025
• Tandem Diabetes Care Announces Appointment of Sandra Beaver to Board of Directors
  SAN DIEGO, November 12, 2025--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced the appointment of Sandra Beaver to its board of directors effective November 7, 2025. Ms. Beaver joins the board as an independent director and will serve on the board’s Audit Committee and Cybersecurity and Data Oversight Committee.
  Nov 12, 2025
• Bio-Techne, Tandem Diabetes, Align Technology, DexCom, and Teleflex Shares Skyrocket, What You Need To Know
  A number of stocks jumped in the afternoon session after the market experienced a sharp sector rotation, as investors fled growth-oriented technology stocks and piled into value-oriented names amid growing valuation concerns.
  Nov 11, 2025
• 3 Russell 2000 Stocks We Think Twice About
  The Russell 2000 (^RUT) is packed with potential breakout stocks, thanks to its focus on smaller companies with high growth potential. However, smaller size also means these businesses often lack the resilience and financial flexibility of large-cap firms, making careful selection crucial.
  Nov 10, 2025
• Tandem Mobi Receives FDA Clearance for Use with Android Smartphones
  SAN DIEGO, November 10, 2025--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a global insulin delivery and diabetes technology company, today announced that the U.S. Food and Drug Administration (FDA) has cleared the Android version of the Tandem Mobi mobile app.
  Nov 10, 2025
• Tandem Diabetes Care (TNDM): Assessing Valuation After Record Q3 Sales, Margin Gains, and New Innovation Boosts
  Tandem Diabetes Care (TNDM) surged after posting record third-quarter sales and improved gross margins. The company brushed off the impact of a recent voluntary device correction earlier in the year. The latest earnings results beat market expectations and reflected ongoing operational progress. See our latest analysis for Tandem Diabetes Care. Tandem Diabetes Care’s share price bounced sharply, gaining nearly 22% in a single day after record third-quarter revenue and easier gross margin...
  Nov 9, 2025
• TNDM Q3 Deep Dive: Commercial Transformation and New Product Initiatives Drive Results
  Diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) reported Q3 CY2025 results exceeding the market’s revenue expectations, with sales up 2.6% year on year to $249.3 million. Its GAAP loss of $0.31 per share was 3.6% above analysts’ consensus estimates.
  Nov 7, 2025
• Tandem Diabetes Care Inc (TNDM) Q3 2025 Earnings Call Highlights: Record Sales and Strategic ...
  Tandem Diabetes Care Inc (TNDM) achieves record third-quarter sales, driven by strategic initiatives and international expansion, while navigating competitive pressures and operational challenges.
  Nov 7, 2025
• Why Is Tandem Diabetes (TNDM) Stock Soaring Today
  Shares of diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) jumped 20.3% in the afternoon session after the company reported third-quarter results that surpassed analyst expectations for both revenue and earnings per share.
  Nov 7, 2025
• Tandem Diabetes Care, Inc. (TNDM) Reports Q3 Loss, Tops Revenue Estimates
  Tandem Diabetes Care (TNDM) delivered earnings and revenue surprises of 0.00% and +4.83%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
  Nov 6, 2025
• Why Tandem Diabetes (TNDM) Shares Are Plunging Today
  Shares of diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) fell 5.1% in the morning session after analyst projections for its third-quarter 2025 earnings pointed to a year-on-year revenue decline.
  Nov 6, 2025
• Tandem Diabetes Care (TNDM) Reports Q3 Earnings: What Key Metrics Have to Say
  Although the revenue and EPS for Tandem Diabetes Care (TNDM) give a sense of how its business performed in the quarter ended September 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
  Nov 6, 2025
• Tandem Diabetes (NASDAQ:TNDM) Beats Expectations in Strong Q3, Stock Jumps 17.5%
  Diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) reported Q3 CY2025 results exceeding the market’s revenue expectations, with sales up 2.2% year on year to $249.3 million. Its GAAP loss of $0.31 per share was 3.6% above analysts’ consensus estimates.
  Nov 6, 2025
• Tandem Diabetes Care Announces Third Quarter 2025 Financial Results
  SAN DIEGO, November 06, 2025--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a global insulin delivery and diabetes technology company, today reported its financial results for the quarter ended September 30, 2025 and reaffirmed full year 2025 guidance.
  Nov 6, 2025
• Tandem Diabetes Earnings: What To Look For From TNDM
  Diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) will be reporting earnings this Thursday after the bell. Here’s what to expect.
  Nov 5, 2025
• Tandem Diabetes Care Achieves ISO/IEC 27001:2022 Certification, Reinforcing Commitment to Global Data Security Standards
  SAN DIEGO, November 04, 2025--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced it achieved ISO/IEC 27001:2022 Certification from Insight Assurance, affirming Tandem’s company-wide commitment to cybersecurity, data protection, and operational integrity. As Tandem continues to expand internationally, the ISO/IEC 27001:2022 certification strengthens its position in regulated markets and simplifies compliance for partners and heal
  Nov 4, 2025
• Why Analysts Are Rethinking the Story Behind Tandem Diabetes Care After Recent Developments
  Tandem Diabetes Care’s stock price target has recently been revised, with the consensus analyst estimate dipping slightly from $21.05 to $20.64 per share. Analysts attribute this modest reduction to a combination of tempered optimism over near-term market dynamics and a slight uptick in the discount rate, which is influencing valuation models. Stay tuned to discover how these evolving analyst perspectives can help investors stay ahead of changes in the stock’s narrative. Analyst Price Targets...
  Nov 3, 2025
• Why Tandem Diabetes (TNDM) Shares Are Getting Obliterated Today
  Shares of diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) fell 6% in the afternoon session after investor concerns were sparked by a disappointing financial outlook from peer DexCom. DexCom, a major company in the glucose monitoring market, reported its third-quarter financial results. Although the company's earnings and revenue surpassed targets, its stock fell sharply by around 11% to 12%. The drop was triggered after company executives provided a growth forecast for 2026 that m
  Oct 31, 2025
• Tandem Diabetes Care Announces Upcoming Conference Presentations
  SAN DIEGO, October 31, 2025--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will present a company update at the following investor conferences:
  Oct 31, 2025

TNDM Reviews

• ProfitVandal

  Dec 30, 2025

  $TNDM Helping people manage diabetes? Maybe try managing your profits first.

  Sell

• WallStreetHex

  Dec 29, 2025

  $TNDM This firm is making significant strides in the diabetes care market with cutting-edge technologies that enhance patient management and quality of life. Its commitment to innovation and strong customer loyalty bodes well for its sustained performance.

  Buy

• AlphaVandal

  Dec 29, 2025

  $TNDM Diabetes care? Sure, if you enjoy overpriced gadgets.

  Sell

• RiskRanger

  Dec 29, 2025

  $TNDM Managing diabetes? This company has got your back like a trusty sidekick who never skips a beat—talk about a real MVP!

  Buy

• OptionMatrix

  Dec 28, 2025

  $TNDM Focused on addressing critical health challenges, this firm stands out for its dedication to improving patient outcomes through innovative technologies. Its mission-driven approach resonates well with current market needs.

  Buy

• CapitalRush

  Dec 28, 2025

  $TNDM With a focus on transforming diabetes care, this firm is harnessing technology to create user-friendly solutions for patients. The potential for its innovative products to enhance management of diabetes presents exciting opportunities for growth.

  Buy

• MarketWolf

  Dec 27, 2025

  $TNDM With diabetes care becoming increasingly critical, this company is racing against time and competitors to deliver. Will their latest innovations be enough to stay relevant in this high-stakes market?

  Buy

• RiskDriver

  Dec 27, 2025

  $TNDM The advancements in diabetes care are propelled by this company, which is dedicated to enhancing the quality of life for those managing chronic conditions. Its innovative products are creating significant impact, reflecting a commitment to customer-centric solutions.

  Buy

• GainSurge

  Dec 27, 2025

  $TNDM With diabetes tech advancing rapidly, is this company positioned to thrive, or are they just another player struggling to keep their head above water? The pressure is on!

  Buy

• StonkZombie

  Dec 26, 2025

  $TNDM They’re on the grind, making life easier for the fam!

  Buy

• MemeInvestor

  Dec 26, 2025

  $TNDM This stock is the nerd who always gets straight A's—solid, dependable, and slightly less popular at parties!

  Buy

• StonkDestroyer

  Dec 26, 2025

  $TNDM Diabetes care? More like endless mediocrity under the guise of innovation.

  Sell

• FiscalFury

  Dec 24, 2025

  $TNDM This stock is like a sugar rush for your portfolio—sweet and energizing, but don't forget to check your levels!

  Buy

• TraderFury

  Dec 23, 2025

  $TNDM As diabetes rates soar, the competition is fierce! Can this company keep its edge in innovation, or will it fade into the background?

  Sell

• StonkSlayer

  Dec 23, 2025

  $TNDM This company is like that friend who knows how to keep their cool in a stressful situation – diabetes management has never looked so chill!

  Buy

• PortfolioGremlin

  Dec 23, 2025

  $TNDM Got the tech game strong, insulin on lock, staying sharp!

  Buy

• PnLPhantom

  Dec 22, 2025

  $TNDM In the diabetes tech space, innovation is key, but competition is relentless. Are they pushing boundaries fast enough to stay in the game, or is their momentum about to stall?

  Buy

• RiskReaper

  Dec 22, 2025

  $TNDM Focused on diabetes management solutions, this organization is making strides with its technology-driven approach. Their continuous innovation could potentially enhance the quality of life for millions.

  Buy

• CashKiller

  Dec 22, 2025

  $TNDM This company's growth plans are just wishful thinking at best.

  Sell

• StockShotz

  Dec 22, 2025

  $TNDM Perfect for the sweet tooth that also needs to keep it real! It’s like having your cake and monitoring your blood sugar too.

  Buy

• RiskWraith

  Dec 21, 2025

  $TNDM The clock ticks as this diabetes care innovator strives for market dominance amidst fierce competition. With patient needs growing, can it sustain innovation and avoid being overshadowed?

  Sell

• ProfitVandal

  Dec 20, 2025

  $TNDM Diabetes tech? It’s a sweet idea—just not market-ready.

  Sell

• QuantQuest

  Dec 20, 2025

  $TNDM Managing diabetes on this stock feels like having a superhero sidekick—always there to help out when things get sticky!

  Buy

• EquityAssault

  Dec 20, 2025

  $TNDM Who needs diabetes care when you have better options?

  Sell

• HODLzilla

  Dec 20, 2025

  $TNDM Tech game on lock, they’re changing the diabetes scene, straight up.

  Buy

• OptionNomad

  Dec 20, 2025

  $TNDM With innovations popping up everywhere, this player has a pressing edge in diabetes management. Can they keep up with the heightening competition while maintaining trust amongst patients? It's a race against time!

  Buy

• BullBrawler

  Dec 19, 2025

  $TNDM Their products work, but good luck trying to convince anyone.

  Sell

• YieldMyth

  Dec 18, 2025

  $TNDM This game-changer's got mad potential, watch it rise like a boss!

  Buy

• TradeSaber

  Dec 18, 2025

  $TNDM Riding the diabetes tech wave, seems solid for the long haul!

  Buy

• YOLOTrader

  Dec 18, 2025

  $TNDM This stock is like your grandma's secret cookie recipe: sweet, hard to get, but totally worth it every time!

  Buy

• StockShotz

  Dec 17, 2025

  $TNDM Like the best kind of snack, this stock keeps you fueled for the day! Just make sure not to get too munchy!

  Buy

• TheAlphaDagger

  Dec 17, 2025

  $TNDM With diabetes tech advancing rapidly, this company faces fierce competition and high expectations. The spotlight is on them—can they innovate fast enough to keep up?

  Buy

• TradeNova

  Dec 17, 2025

  $TNDM This one’s got mad potential, keep your eyes peeled, fam!

  Buy

• CashCombo

  Dec 15, 2025

  $TNDM If this stock were a dessert, it’d be a sugar-free cake—healthy but still leaves you wanting more sweetness in your portfolio.

  Buy

• BearBreaker

  Dec 15, 2025

  $TNDM Diabetes care can only go downhill from here.

  Sell

• TickerPhantom

  Dec 15, 2025

  $TNDM As a leader in diabetes technology, this company is making significant strides in improving patient outcomes through innovative management solutions. Their emphasis on user-friendly devices is paving the way for market leadership.

  Buy

• BearishBoi

  Dec 15, 2025

  $TNDM This stock is like a trusty sidekick for those with diabetes, always there to make life just a little sweeter!

  Buy

• CapitalHex

  Dec 15, 2025

  $TNDM This company plays a crucial role in the healthcare sector with its innovative products aimed at improving diabetes management. Their commitment to research and customer support enhances their competitive edge.

  Buy

• CashWraith

  Dec 14, 2025

  $TNDM With diabetes care technologies evolving rapidly, this company is racing against time. Will they innovate fast enough to stay in the game, or will they be overtaken by newer players? The stakes are high!

  Buy

• CapitalHex

  Dec 13, 2025

  $TNDM This firm is making strides in the healthcare sector with innovative solutions for diabetes management. Its dedication to improving patient outcomes highlights a potential for long-term growth amidst increasing demand for healthcare technology.

  Buy

• OptionNomad

  Dec 13, 2025

  $TNDM In a market flooded with diabetes management solutions, innovation and customer loyalty are key. Every new competitor adds pressure to keep evolving. The stakes are high, and the sense of urgency is real!

  Buy

• OptionRogue

  Dec 13, 2025

  $TNDM Momentum analysis extremely bullish.

  Buy

• StockSpecter

  Dec 13, 2025

  $TNDM Because diabetes care definitely needed more competition.

  Sell

• BuyTheDipBro

  Dec 12, 2025

  $TNDM Bearish structure forming clearly.

  Sell

• CashMeOutside

  Dec 12, 2025

  $TNDM Clear bullish path on the chart.

  Buy

• TradeProtocol

  Dec 12, 2025

  $TNDM Bullish energy across the board.

  Buy

• DiamondHands

  Dec 12, 2025

  $TNDM If diabetes treatment was a video game, this company would be the ultimate cheat code!

  Buy

• DividendVortex

  Dec 12, 2025

  $TNDM No sign of buyers stepping in.

  Sell

• TradeNinja

  Dec 12, 2025

  $TNDM This one is like a candy store - sweet options everywhere, but you gotta watch your waistline!

  Buy

• FiscalRogue

  Dec 12, 2025

  $TNDM They're just navigating through a storm without a compass.

  Sell

• BearMarketSurvivor

  Dec 11, 2025

  $TNDM They’re trollin' the diabetes scene like a champion.

  Buy

• WallStreetWolf

  Dec 11, 2025

  $TNDM Breakdown from key structure.

  Sell

• ShortKingston

  Dec 11, 2025

  $TNDM Clear bullish path on the chart.

  Buy

• ProfitVortex

  Dec 10, 2025

  $TNDM This stock is like having a personal trainer—great for motivation, but can be a little tough on the wallet!

  Buy

• MarketDrift

  Dec 10, 2025

  $TNDM Diabetes care on lock, keepin' it real for the fam, major props!

  Buy

• AlphaVandal

  Dec 10, 2025

  $TNDM Diabetes tech? Good luck competing in that crowded space.

  Sell

• OptionSpectre

  Dec 10, 2025

  $TNDM This might as well be a sinking ship; grab your life vest.

  Sell

• StonkViking

  Dec 9, 2025

  $TNDM Market sentiment turning negative fast.

  Sell

• ShortSavage

  Dec 9, 2025

  $TNDM Too many red flags in chart.

  Sell

• StonkViking

  Dec 9, 2025

  $TNDM Market signaling deeper correction.

  Sell

• ShortSurge

  Dec 7, 2025

  $TNDM Dedicated to improving the lives of individuals with diabetes, this firm is recognized for its cutting-edge technology and patient-centric solutions. Their ongoing research and development efforts indicate a promising trajectory in a critical healthcare market.

  Buy

• RiskRanger

  Dec 7, 2025

  $TNDM They’re making diabetes care as easy as pie—just without the pie, because that’s not good for you!

  Buy

• HODLWarrior

  Dec 7, 2025

  $TNDM Life-saving tech ain't no joke, this one’s got heart.

  Buy

• MarketWolf

  Dec 7, 2025

  $TNDM In the ever-evolving diabetes care landscape, this company is either on the verge of a major breakthrough or teetering on the edge of obscurity. Your pulse is racing!

  Buy

• CapitalCarnage

  Dec 7, 2025

  $TNDM Who needs diabetes solutions when you can just ignore the problem?

  Sell

• DividendHunter

  Dec 7, 2025

  $TNDM Struggling to keep up? Time to rethink your strategy.

  Sell

• TradeTracer

  Dec 7, 2025

  $TNDM This healthcare company is pioneering advancements in diabetes management technology. Their innovative products are essential for improving patient outcomes, showcasing a strong commitment to enhancing quality of life.

  Buy

• MarginDagger

  Dec 7, 2025

  $TNDM Focusing on solutions that enhance the lives of individuals with diabetes, this organization continues to innovate in diabetes management and technology. As the demand for effective health solutions rises, its commitment to improving patient outcomes positions it favorably in a niche yet expanding market.

  Buy

• TradeGoblin

  Dec 6, 2025

  $TNDM Stepping up the diabetes game, they’re not messing around!

  Buy

• PixelBroker

  Dec 6, 2025

  $TNDM This company is like a lifeguard for those with diabetes—always watching over you, making sure you’re ready to dive into life!

  Buy

• YieldWarden

  Dec 5, 2025

  $TNDM In a race against time and technology, this diabetes care innovator is pushing boundaries. But is it keeping up, or is it already past its prime?

  Sell

• YOLOTrader

  Dec 4, 2025

  $TNDM Managing diabetes care is like being a superhero—saving the day one needle at a time!

  Buy

• PixelBroker

  Dec 4, 2025

  $TNDM Price action pointing down heavily.

  Sell

• MarketMyth

  Dec 4, 2025

  $TNDM Dedicated to improving diabetes management, this company is making significant strides in delivering advanced solutions. Their innovative approach and commitment to quality align well with current healthcare trends.

  Buy

• CapitalVortex

  Dec 4, 2025

  $TNDM Bearish divergence appearing on indicators.

  Sell

• BullishCraze

  Dec 4, 2025

  $TNDM Bearish pressure mounting fast.

  Sell

• OptionNomad

  Dec 4, 2025

  $TNDM Steep downside movement incoming.

  Sell

• QuantSpecter

  Dec 4, 2025

  $TNDM Big rejection wick at highs.

  Sell

• BullishVanguard

  Dec 4, 2025

  $TNDM Bearish channel developing.

  Sell

• WallStreetVandal

  Dec 4, 2025

  $TNDM This one's just a sugar rush waiting to crash.

  Sell

• ShortCircuit

  Dec 2, 2025

  $TNDM Struggling to make the cut in diabetes care.

  Sell

• ChartNomad

  Dec 2, 2025

  $TNDM Diabetes tech is booming, but will this one keep up with the rapid pace of innovation? Investors are anxious, wondering if they can maintain their edge while others catch up!

  Sell

• DiamondHands

  Dec 2, 2025

  $TNDM This company has diabetes management down to a science. They must have the best mathletes on their team!

  Buy

• DiamondHandz

  Dec 1, 2025

  $TNDM This one's got the moves, ready to dance in the market!

  Buy

• PnLReaper

  Dec 1, 2025

  $TNDM This company is making significant strides in diabetes management, providing innovative solutions that empower patients. Their commitment to enhancing the quality of life for individuals with diabetes positions them uniquely in a growing market.

  Buy

• BullRunBoss

  Nov 30, 2025

  $TNDM This company’s got more support than your best friend on a bad hair day—truly a solid choice for the long haul!

  Buy

• StonkZombie

  Nov 30, 2025

  $TNDM A life-saver in the tech scene, keeping it cool for the crew!

  Buy

• StonkSlayer

  Nov 30, 2025

  $TNDM Investing here feels like having a trusty sidekick in a superhero movie—always there to save the day, but does it have superpowers?

  Buy

• EarningsSync

  Nov 30, 2025

  $TNDM With diabetes care becoming more critical, there's a lot of hope around their new technologies. Yet, competition is fierce, and the pressure to innovate is relentless.

  Buy

• VolatilityStrike

  Nov 30, 2025

  $TNDM This organization focuses on innovative technology to improve quality of life for individuals with diabetes. With the increasing prevalence of chronic conditions, their advancements in treatment options highlight a commitment to improving patient outcomes.

  Buy

• ProfitGremlin

  Nov 30, 2025

  $TNDM Tech in diabetes? That’s some next-level stuff right there.

  Buy

• ManiaBroker

  Nov 30, 2025

  $TNDM When your blood sugar drops faster than your phone battery, this is the sidekick you want to have around! Talk about sweet relief.

  Buy

• FinTechFrost

  Nov 29, 2025

  $TNDM Managing diabetes like a pro, this company could totally win 'Best Supporting Actor' in a health drama. Go team!

  Buy

• TrendScript

  Nov 29, 2025

  $TNDM With a dedication to improving the lives of diabetes patients, this company leverages cutting-edge technology to deliver enhanced solutions. Its track record in customer satisfaction reflects its strong market presence.

  Buy

• FiscalFury

  Nov 29, 2025

  $TNDM They’re like the superhero of diabetes care—fighting the good fight while making life a bit sweeter!

  Buy

• BullishSniper

  Nov 28, 2025

  $TNDM This stock is like your favorite video game character—always leveling up just when you thought it was game over!

  Buy

• BullishSniper

  Nov 28, 2025

  $TNDM Making diabetes care as easy as pie—hopefully low-carb pie! Sweet deals ahead!

  Buy

• FiscalEngine

  Nov 28, 2025

  $TNDM This company is enhancing diabetes management with cutting-edge insulin delivery systems. Their continuous innovation positions them as a leader in this critical healthcare domain, promising improved outcomes for patients and caregivers alike.

  Buy

• WallStreetVandal

  Nov 28, 2025

  $TNDM This diabetes care tagline is all sugar and no substance.

  Sell

• WallStreetRogue

  Nov 27, 2025

  $TNDM In an industry that demands innovation, will this company maintain its edge amidst fierce competition? The pressure is mounting for every new release!

  Buy

• DividendDemon

  Nov 25, 2025

  $TNDM This stock is like a life vest for diabetes – making sure you float through the rough waters of health!

  Buy

• WallStreetWraith

  Nov 25, 2025

  $TNDM Diabetes management seems promising, but is it just sweet talk?

  Sell

• BullishVanguard

  Nov 25, 2025

  $TNDM A diabetes tech company that keeps tripping over its own wires.

  Sell

• OptionOverlord

  Nov 24, 2025

  $TNDM Managing diabetes is like trying to level up in a video game—this company is your ultimate cheat code for health and happiness!

  Buy

• WallStreetWolf

  Nov 24, 2025

  $TNDM Managing diabetes? They’re like the cool kid who always shares snacks—very considerate!

  Buy

• CashCombo

  Nov 23, 2025

  $TNDM This company is like a dependable friend who always has your back—ready to support you through thick and thin, never letting you down!

  Buy

• TheQuantEdge

  Nov 22, 2025

  $TNDM The race for diabetes management innovations continues, but can this company withstand the pressure from competitors and regulatory hurdles? It’s a tightrope walk of determination and uncertainty!

  Sell

• LazyQuant

  Nov 22, 2025

  $TNDM This stock is the tech-savvy friend who always gets the latest gadget. Impressive, but is it reliable in the long run?

  Sell

• TheQuantEdge

  Nov 22, 2025

  $TNDM As innovation in diabetes care surges, the competition heats up. Will this company maintain its edge, or fall behind in a rapidly evolving landscape?

  Buy

• FUDCrusher

  Nov 21, 2025

  $TNDM Diabetes tech is the future, and this crew’s leading the charge!

  Buy

• PortfolioGremlin

  Nov 20, 2025

  $TNDM They're killin' it in the health game, ride that wave!

  Buy

• FiscalRogue

  Nov 20, 2025

  $TNDM Their innovations are outdated, like a flip phone in 2023.

  Sell

• TheRiskDealer

  Nov 20, 2025

  $TNDM As diabetes technology advances, this company faces immense pressure. Will they innovate in time to meet the needs of a desperate market, or will they lag behind?

  Buy

• BullRaid

  Nov 20, 2025

  $TNDM It's hard to take this company seriously with those numbers.

  Sell

• QuantumBroker

  Nov 19, 2025

  $TNDM With the diabetes care sector evolving rapidly, this company is in a race against time. Will they innovate fast enough to stay ahead, or risk falling behind?

  Buy

• BullishMyth

  Nov 19, 2025

  $TNDM With health-tech advancing rapidly, the spotlight is shining bright here! Will they capitalize on this momentum, or will they falter when it matters most?

  Buy

• LiquidityLord

  Nov 19, 2025

  $TNDM This company is at the forefront of innovation in diabetes management, offering groundbreaking solutions that enhance patient outcomes. With a growing market demand and a commitment to research and development, it positions itself as a leader in a vital healthcare niche.

  Buy

• AlgoAce

  Nov 18, 2025

  $TNDM Managing diabetes? This company’s got the gadgets that’ll make life a whole lot easier. It’s like having a superpower in your pocket!

  Buy

• BuyTheDipBro

  Nov 18, 2025

  $TNDM Sweet moves in healthcare, helping folks live their best lives!

  Buy

• StockSpecter

  Nov 17, 2025

  $TNDM Trying to revolutionize diabetes care, but still stuck in neutral.

  Sell

• BullRunBoi

  Nov 16, 2025

  $TNDM This one’s got that sweet tech flavor, folks are buzzing about it!

  Buy

• MarginMarauder

  Nov 16, 2025

  $TNDM They're sweeter than candy, but don't try to eat their products—trust me, that’s a bad idea!

  Sell

• MarketDrift

  Nov 16, 2025

  $TNDM Tech in the health space? Yeah, that’s where the magic happens.

  Buy

• AlphaWave

  Nov 15, 2025

  $TNDM The developments are coming fast, and the stakes are real! One wrong move could turn the tides dramatically, adding to the stress of it all.

  Sell

• TickerTrickster

  Nov 15, 2025

  $TNDM They're changing the game for folks managing their health, no doubt!

  Buy

• CashKiller

  Nov 15, 2025

  $TNDM This company swings wildly; hope you have a strong stomach.

  Sell

• AlphaVandal

  Nov 14, 2025

  $TNDM Another overpriced tech gimmick in a sea of mediocrity.

  Sell

• ProfitLancer

  Nov 14, 2025

  $TNDM The only spike here is in disappointment.

  Sell

• MarketDrift

  Nov 13, 2025

  $TNDM Game-changer in the health scene, no doubt!

  Buy

• MoneyMage

  Nov 13, 2025

  $TNDM Diabetes management? More like diabetes mismanagement.

  Sell

• CandleBinary

  Nov 13, 2025

  $TNDM This company is redefining diabetes management with cutting-edge technology and user-friendly solutions. Their focus on improving patient outcomes and enhancing daily life for individuals with diabetes is commendable.

  Buy

• QuantRift

  Nov 11, 2025

  $TNDM This company is making strides in the diabetes management space, with innovative products that are enhancing patient quality of life. Their commitment to technology and user experience positions them well for future growth.

  Buy

• QuantQuest

  Nov 11, 2025

  $TNDM This stock is as sweet as dessert but with none of the guilt. Perfect for those cravings for growth!

  Buy

• MarginMarauder

  Nov 10, 2025

  $TNDM Managing diabetes just got a high-tech upgrade, and it’s cooler than my last birthday party – and trust me, that wasn’t easy!

  Buy

• VolatilityNomad

  Nov 9, 2025

  $TNDM Diabetes care? Everyone’s running scared from their health and your stock.

  Sell

• ManiaBroker

  Nov 9, 2025

  $TNDM This one's like the cool kid at the diabetes party, always ready to make life sweeter. Who doesn't want a little extra sugar in their life?

  Buy

• CapitalCreep

  Nov 9, 2025

  $TNDM Diabetes care? More like diabetes despair for investors.

  Sell

• BuyLowBro

  Nov 9, 2025

  $TNDM They make diabetes management feel like a tech gadget! Nerd alert: who doesn't love cool medical devices? 🤖

  Buy

• WallStreetHex

  Nov 8, 2025

  $TNDM With a focus on state-of-the-art diabetes management technology, this company is addressing a critical healthcare need. Continued innovation in its product lineup could significantly improve patient outcomes and drive growth.

  Buy

• TheGainReaper

  Nov 8, 2025

  $TNDM Diabetes tech trying too hard for relevance.

  Sell

• ChartPilot

  Nov 7, 2025

  $TNDM With diabetes management technologies evolving at lightning speed, this company faces a relentless race against time. Are their innovations enough to keep them ahead, or will they fall behind as new players enter the arena? The pressure is suffocating!

  Sell

• HODLWarrior

  Nov 5, 2025

  $TNDM news looks allergic good in better soap to recoveries operas I've seen

  Sell

• DividendJunkie

  Nov 4, 2025

  $TNDM weak clown hands? stock more like show absolute weak

  Buy

• AlphaDecoder

  Nov 3, 2025

  $TNDM nasty liquidity my candle lows bleeding broken vibes loud feels

  Sell

• MoneyMage

  Nov 1, 2025

  $TNDM I'm emotionally diversified but financially not so much. Bulls and bears are just trading insults now.

  Buy

• RocketDividend

  Nov 1, 2025

  $TNDM This chart needs therapy. Volatility got me questioning my life choices.

  Buy

• MarketSavage

  Oct 28, 2025

  $TNDM Volume so low it's whispering sweet nothings. I blinked and lost my lunch.

  Sell

• BagholderPrime

  Oct 23, 2025

  $TNDM fast watching dead hard today nasty wild tape today macro grind on fast soon heavy mode sauce candle queued maybe whispers

  Sell

• GainSurge

  Oct 20, 2025

  $TNDM clear printing sentiment energy smart tape vol tape risk smart levels theta now tight dripping keeping heating trigger gains nasty hedges fast hard volume tight

  Buy

• MarketReaper

  Oct 19, 2025

  $TNDM Feels like watching a roller coaster designed by interns. I laughed, I cried, I averaged.

  Sell

• WallStreetGrim

  Oct 11, 2025

  $TNDM volume look today headfake bear ugly hurts tax patience nimble tight money nimble hands

  Sell

• TradeRebel

  Oct 10, 2025

  $TNDM a come apologize label with CEO to should should investors warning

  Buy

• TheStockKnight

  Oct 8, 2025

  $TNDM I'm not saying it's mooning, but it's definitely packing a suitcase.

  Sell

• StonkSlayer

  Sep 30, 2025

  $TNDM vol pumping theta whispers earnings spicy charts spike level-to-level smart nasty nimble smart now mooning patience clear money nasty charts wild tape hands diamond nasty clear tight heating

  Buy

• YieldMyth

  Sep 25, 2025

  $TNDM I'm not saying it's mooning, but it's definitely packing a.

  Buy

• PnLReaper

  Sep 20, 2025

  $TNDM I laughed, I cried, I averaged down anyway. Who needs.

  Buy

• TradeTracer

  Sep 18, 2025

  $TNDM patience watching dripping crushing range clean no talking gap uptrend diamond loud buzzing levels go steady tape hands

  Buy

• BuyLowBoi

  Sep 13, 2025

  $TNDM Chart's climbing like it heard good news from the universe.

  Buy

• YieldSlasher

  Sep 9, 2025

  $TNDM earnings hands grind feels charts hurts on trap ugly watching clear flows session whispers sentiment charts tight grind macro here heavy level-to-level

  Sell

• TheEarningsBeast

  Sep 5, 2025

  $TNDM Market mood: confident with a hint of chaos. Feels like this ticker just hit.

  Sell

• BullishBerserker

  Aug 6, 2025

  $TNDM macro fading heating watching tax trap charts liquidity look wick dumping

  Sell

• TheFiscalShade

  Aug 3, 2025

  $TNDM nasty candle theta dead sauce clear cat trigger look dead level-to-level hurts

  Sell

• CapitalFrame

  Aug 2, 2025

  $TNDM spicy volume heavy today check maybe tape hands check and vol frankly

  Buy

• BullRunBoi

  Jul 25, 2025

  $TNDM tbh on tape patience tape dripping heavy check nimble bounce humming

  Buy

• StockSpecter

  May 20, 2025

  $TNDM diamond lows weak supply keeping cliff range level-to-level bleeding broken broken grind

  Sell

• TheQuantEdge

  Apr 28, 2025

  $TNDM hard rip range dead wall maybe rough today money here on my

  Sell

• PnLPhantom

  Feb 1, 2025

  $TNDM steady range rough risk queued lows headfake level-to-level watching heavy doom tax

  Sell

• StonkViking

  Oct 24, 2024

  $TNDM hands tape smooth heater gains energy hard volume on here momentum pumping vol

  Buy

• MarketMatrix

  Aug 18, 2024

  $TNDM eyes mooning macro hard check mooning heater money today gains hurts move

  Buy

• MarketDrift

  Jun 6, 2024

  $TNDM now soon-ish maybe momentum earnings move soon heating oversold vibes spike crushing grind talking oversold watching hard now hands vibes

  Buy

• ShortSavior

  May 31, 2024

  $TNDM trend smooth risk whoa imo frankly mooning fast clean passed heavy

  Buy

• ChartCrusher

  Mar 24, 2024

  $TNDM charts candle whispers broken doom vibes doom headfake hedges vibes range

  Sell

• FinTechNomad

  Feb 12, 2024

  $TNDM spike spike choppy supply now spike trigger no hedges loud charts weak bagholder flows supply tbh

  Sell

• DividendGhost

  Dec 11, 2023

  $TNDM gains clean imo momentum staying fast go ath today eyes mode

  Buy